T-Line TCS (Tissue Control Suture)

About Deep Blue Medical Advances

Deep Blue Medical Advances is a private, clinical-stage medical device innovator targeting the $1.1B+ global hernia repair market and broader soft tissue surgery. Its flagship product, the T-Line® Hernia Mesh, is commercially available in the US, with a pipeline including the T-Line® TCS (Tissue Control Suture), a scaffold for breast surgery, and an Anchor Clip. The company's technology platform is centered on novel reinforcement structures to prevent suture pull-through, a leading cause of hernia recurrence, positioning it to address a significant unmet clinical need with potential for improved patient outcomes and surgical efficiency.

Therapeutic Areas